{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Radkiewicz C"],"funding":["Region Stockholm"],"pagination":["pkad038"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10279998"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["7(3)"],"pubmed_abstract":["Incidence and mortality are default measures to describe cancer trends. Mortality compounds incidence and survival but not age at death. We calculated years of life lost (YLL) due to 1 of the 10 solid tumors causing most deaths (lung, colorectal, prostate, pancreatic, breast, hepatobiliary, urinary, central nervous system, gastric, melanoma) using Swedish National Cancer and Cause of Death Registers. Comparing YLL with mortality in 2019, lung (43 152 YLL) and colorectal (32 340 YLL) cancer remained at the top, pancreatic cancer was upranked fourth to third (22 592 YLL) and breast cancer fifth to fourth (21 810 YLL), while prostate cancer was downranked third to fifth (17 380 YLL). Assessing YLL over 2010-2019, women lost consistently more life years because of lung and pancreatic cancer. A"],"journal":["JNCI cancer spectrum"],"pubmed_title":["Reranking cancer mortality using years of life lost."],"pmcid":["PMC10279998"],"funding_grant_id":["FoUI-963792"],"pubmed_authors":["Andersson TM","Lagergren J","Radkiewicz C"],"additional_accession":[]},"is_claimable":false,"name":"Reranking cancer mortality using years of life lost.","description":"Incidence and mortality are default measures to describe cancer trends. Mortality compounds incidence and survival but not age at death. We calculated years of life lost (YLL) due to 1 of the 10 solid tumors causing most deaths (lung, colorectal, prostate, pancreatic, breast, hepatobiliary, urinary, central nervous system, gastric, melanoma) using Swedish National Cancer and Cause of Death Registers. Comparing YLL with mortality in 2019, lung (43 152 YLL) and colorectal (32 340 YLL) cancer remained at the top, pancreatic cancer was upranked fourth to third (22 592 YLL) and breast cancer fifth to fourth (21 810 YLL), while prostate cancer was downranked third to fifth (17 380 YLL). Assessing YLL over 2010-2019, women lost consistently more life years because of lung and pancreatic cancer. A","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-04T12:10:48.116Z","creation":"2025-02-19T03:56:17.499Z"},"accession":"S-EPMC10279998","cross_references":{"pubmed":["37252821"],"doi":["10.1093/jncics/pkad038"]}}